Skip to main content

and
  1. No Access

    Article

    N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway

    Background: Renal fibrosis is the primary pathway in the progression of chronic kidney disease (CKD) towards end-stage renal failure. The currently used drugs currently are ineffective, and their mechanisms of...

    Wenxiu Yu, Congcong Zeng, Chenggong Wang, Sining Jia in Cell Biochemistry and Biophysics (2024)

  2. Article

    Open Access

    Efficacy of Traditional Chinese Medicine, Maxingshigan-Wei**g in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial

    We aimed to test our expectation that additional administration of Traditional Chinese medicine (TCM), maxingshigan-wei**g decoction, is more effective in the management of COVID-19 patients compared to those...

    Congcong Zeng, Zhengzhong Yuan, **aoqiong Pan, Jizhou Zhang, Jiahui Zhu, Fan Zhou in Trials (2020)

  3. Article

    Open Access

    Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial

    Insomnia seriously affects people’s normal lives and work. However, effective treatment strategies are scarce. The purpose of this study is to explore the efficacy and safety of Jiao-tai-wan (JTW) for ameliora...

    Congcong Zeng, ** Liu, Lufeng Hu, Yuan Feng, Nengzhi **a, Haihuan Zeng, Lin Luo in Trials (2020)